Structure Therapeutics Shares Rise 60% as Deep Track Capital Adds $11.5M Stake
Deep Track Capital increased its stake in Structure Therapeutics (NASDAQ:GPCR) by purchasing an additional $11.5 million worth of shares during the first quarter, according to a May 15 SEC filing. The fund now holds 3.37% of its reportable U.S. equity holdings in GPCR as the stock has surged over 60% year-to-date.
Tickers: $GPCR
Topics: Biotech Institutional Investment Structure Therapeutics